Connection
Ruth Napier to Mycobacterium tuberculosis
This is a "connection" page, showing publications Ruth Napier has written about Mycobacterium tuberculosis.
|
|
Connection Strength |
|
 |
|
 |
|
0.781 |
|
|
|
-
Napier RJ, Shinnick TM, Kalman D. Back to the future: host-targeted chemotherapeutics for drug-resistant TB. Future Microbiol. 2012 Apr; 7(4):431-5.
Score: 0.302
-
Napier RJ, Rafi W, Cheruvu M, Powell KR, Zaunbrecher MA, Bornmann W, Salgame P, Shinnick TM, Kalman D. Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis. Cell Host Microbe. 2011 Nov 17; 10(5):475-85.
Score: 0.295
-
Gold MC, Napier RJ, Lewinsohn DM. MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosis. Immunol Rev. 2015 Mar; 264(1):154-66.
Score: 0.093
-
Baldwin PR, Reeves AZ, Powell KR, Napier RJ, Swimm AI, Sun A, Giesler K, Bommarius B, Shinnick TM, Snyder JP, Liotta DC, Kalman D. Monocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis. Eur J Med Chem. 2015 Mar 06; 92:693-9.
Score: 0.092
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|